ResoTher Pharma
PrivateLast Round
Reverse Merger
Mar 30, 2026
Est. Valuation
$36.58M
Total Funding Raised
$2.67M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ResoTher Pharma is a biotechnology company that develops peptide-based therapeutics intended for inflammation resolution in cardiovascular conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ResoTher Pharma Comparables
Compare ResoTher Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Serpin Pharma | 78% | |
| Novo Nordisk | 73% | |
| Epoqe Pharma | 73% |
ResoTher Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Reverse Merger | Mar 30, 2026 | ||||
| Grant | Nov 7, 2023 | ||||
| Private Placement | May 4, 2021 | ||||
| Private Placement | Nov 1, 2019 | ||||
| Seed | Nov 17, 2017 |
Key People
Founding team and executive leadership
ResoTher Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Axilium Capital | Private Placement |
| Innovation Fund Denmark | Private Placement |
| European Innovation Council Fund | Grant |
| North Finance A/S | Private Placement |
| European Commission | Private Placement |
| Capnova | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 633% MoM.
- Jul 26, 2026
Monthly visitors grew 47% MoM.
Recent news
Latest coverage and updates
- is_developingSep 15, 2026
ResoTher Pharma ApS is developing class of resolution therapeutics.
ResoTher Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ResoTher Pharma's valuation, stock price, and market status.
Is ResoTher Pharma a public or private company?
ResoTher Pharma is a private company.
What is the current stock price of ResoTher Pharma?
ResoTher Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is ResoTher Pharma worth (valuation)?
ResoTher Pharma's valuation is estimated at $36.6M based on funding round data.
Can I buy ResoTher Pharma stock?
ResoTher Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ResoTher Pharma's last funding round?
ResoTher Pharma's most recent funding round was Reverse Merger on March 30, 2026.
Who are the main investors in ResoTher Pharma?
Key investors in ResoTher Pharma include Capnova.
Will ResoTher Pharma IPO soon?
No public IPO plans have been announced for ResoTher Pharma.
How can I track ResoTher Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ResoTher Pharma's secondary market activity and sign up for updates.